Safety and efficacy of transdermal fentanyl in patients with cancer pain: Phase IV, Turkish oncology group trial

European Journal of Cancer Care

Volumn 16, Issue 1, 2007, Pages 67-73

  Komurcu S ^a   Turhal, S ^b   Altundag K ^c   Atahan, L ^c   Turna, H S ^d   Manavoglu O ^e   Yavuz, A A ^f   Ozkok S ^g   Aliustaoglu M ^b   Altinbas M ^h   Pak, Y ^a   Cooper, R ⁱ   Yaylaci, M ^a   Demirkan, B ⁱ   Sarihan, S ^e   Ozdemir F ^f  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e ULUDAG UNIVERSITY   (Turkey)

^f KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^g EGE UNIVERSITY   (Turkey)

^h ERCIYES UNIVERSITY   (Turkey)

ⁱ DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Cancer pain; Opioids; Transdermal fentanyl

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PAIN; PAIN ASSESSMENT; PHASE 4 CLINICAL TRIAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANALGESICS, OPIOID; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TURKEY;

EID: 33846183581     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00707.x     Document Type: Article

References (19)

1. Ahmedzai S., Allan E., Fallon M., Finlay I.G., Hanks G.W., Hanna M. (1994) Transdermal fentanyl in cancer pain. Journal of Drug Development 6, 93-97.
2. Austin K.L., Stapleton J.V. & Mather L.E. (1980) Multiple intramuscular injections: a major source of variability in analgesic response to meperidine. Pain 8, 47.
3. Finch J.S. & de Kornfeld T.J. (1964) Clinical investigation of the analgesic potency and respiratory depressant activity of fentanyl, a new narcotic analgesic. Journal of Clinical Pharmacology 7, 46-51.
4. Foley K.M. (1981) Current issues in the management of cancer pain: memorial Sloan-Kettering Cancer Center. National Institute of Drug Abuse Research Monograph Series 36, 169-181.
5. Hall G.M. (1980) Fentanyl and the metabolic response to surgery. British Journal of Anaesthesia 52, 561-562.
6. Homesley H.D., Welander C.E. & Muss H.B. (1986) Dosage range study of morphine sulphate controlled release. American Journal of Clinical Oncology 9, 449-453.
7. Huynh N.H., Tyrefors N., Ekman L. & Johansson M. (2005) Determination of fentanyl in human plasma and fentanyl and norfentanyl in human urine using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 37, 1095-1100.
8. Joranson D.E., Ryan K.M., Gilson A.M. & Dahl J. (2000) Trends in medical use and abuse of opioid analgesics. Journal of the American Medical Association 283, 1710-1714.
9. Lorvidhaya V., Katanyoo K., Srisomboon J., Suprapaphorn P. & Cheewakriangkrai C. (2004) Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer related pain. Journal of the Medical Association of Thailand 87, 319-325.
10. McGivney W.T. & Cooks G.M. (1984) The care of patients with severe chronic pain and terminal illness. Journal of the American Medical Association 251, 1182-1188.
11. Markman M. (2005) Supportive care. Cancer Chemotherapy and Biological Response Modifiers 22, 677-686.
12. Morita T., Takigawa C., Onishi H., Tajima T., Tani K., Matsubara T., Miyoshi I., Ikenaga M., Akechi T. & Uchitomi Y. (2005) Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. Journal of Pain and Symptom Management 30, 96-103.
13. Mystakidou K., Parpa E., Tsilika E., Katsouda E., Kouloulias V et al. (2004) Pain management of cancer patients with transdermal fentanyl study of 1828 step I, II and III transfers. Journal of Pain 5, 119-132.
14. Tawfik M.O., Bryuzin V. & Kourteva G. (2004) Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain. Current Medical Research and Opinion 20, 259-267.
15. Van Seventer R., Smit J.M., Schipper R.M., Wicks M.A. & Zuurmond W.W. (2003) Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Current Medical Research and Opinion 19, 457-469.
16. Vielvoye-Kerkmeer A.P., Mattern C. & Vitendaal M.P. (2000) Transdermal fentanyl in opioid naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid naive patients and a group using codeine. Journal of Pain and Symptom Management 19, 185-192.
17. Wuster M., Schulz R. & Hertz A. (1980) The direction of opioid agonists towards mu-, delta- and epsilon-receptors in the VAS deference of the mouse and rat. Life Science 27, 163-170.
18. Yeo W., Lam K.K., Chan A.T., Leug T.W., Nip S.Y. & Johnson P.J. (1997) Transdermal fentanyl for severe cancer related pain. Palliative Medicine 11, 233-239.
19. YuS.Y., Sun Y., Wu Y.L., Qin S.K., Xie G.R., Liu S.J., Sui G.J. & Zhang H.C. (2005) Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients. Zhonghua Zhong Liu Za Zhi 27, 369-372.